Literature DB >> 32211809

An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic-COVID-19 and Cardiovascular Diseases.

Chengzhi Yang1, Zening Jin1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32211809     DOI： 10.1001/jamacardio.2020.0934

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  44 in total

Review 1.  Cardiovascular Impacts on COVID-19 Infected Patients.

Authors:  Somasundaram Raghavan; R Gayathri; Sudhakar Kancharla; Prachetha Kolli; J Ranjitha; Vijayalakshmi Shankar
Journal:  Front Cardiovasc Med       Date:  2021-05-13

2.  Cardiovascular impact of COVID-19: an array of presentations.

Authors:  Hira Maab; Faryal Mustafa; Syeda Javeria Shabbir
Journal:  Acta Biomed       Date:  2021-05-12

3.  COVID-19 infection in left ventricular assist device patients.

Authors:  Antonio Piperata; Tomaso Bottio; Gino Gerosa
Journal:  J Card Surg       Date:  2020-08-21       Impact factor: 1.620

4.  Infection-control practices in the COVID-19 pandemic call for an evidence-based management system in psychiatric hospitals.

Authors:  Mi Yang; Manxi He; Shan Gao
Journal:  Asian J Psychiatr       Date:  2020-08-29

Review 5.  COVID-19 and ethnicity: A novel pathophysiological role for inflammation.

Authors:  Abhinav Vepa; Joseph P Bae; Faheem Ahmed; Manish Pareek; Kamlesh Khunti
Journal:  Diabetes Metab Syndr       Date:  2020-06-30

6.  Individualized prediction nomograms for disease progression in mild COVID-19.

Authors:  Jiaofeng Huang; Aiguo Cheng; Su Lin; Yueyong Zhu; Gongping Chen
Journal:  J Med Virol       Date:  2020-05-17       Impact factor: 20.693

Review 7.  The "Three Italy" of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia.

Authors:  Carla Prezioso; Maria Elena Marcocci; Anna Teresa Palamara; Giovanna De Chiara; Valeria Pietropaolo
Journal:  J Neurovirol       Date:  2020-06-16       Impact factor: 2.643

Review 8.  The COVID-19 pandemic and physical activity.

Authors:  Jeffrey A Woods; Noah T Hutchinson; Scott K Powers; William O Roberts; Mari Carmen Gomez-Cabrera; Zsolt Radak; Istvan Berkes; Anita Boros; Istvan Boldogh; Christiaan Leeuwenburgh; Hélio José Coelho-Júnior; Emanuele Marzetti; Ying Cheng; Jiankang Liu; J Larry Durstine; Junzhi Sun; Li Li Ji
Journal:  Sports Med Health Sci       Date:  2020-05-30

9.  Defining heart disease risk for death in COVID-19 infection.

Authors:  J Li; T Guo; D Dong; X Zhang; X Chen; Y Feng; B Wei; W Zhang; M Zhao; J Wan
Journal:  QJM       Date:  2020-12-01

Review 10.  Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure.

Authors:  Iman Razeghian-Jahromi; Mohammad Javad Zibaeenezhad; Zhibing Lu; Elyaspour Zahra; Razmkhah Mahboobeh; Vicenzo Lionetti
Journal:  Heart Fail Rev       Date:  2021-03       Impact factor: 4.654
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.